Annual Net Margin
-153.84%
+93.13%+37.71%
December 31, 2023
Summary
- As of February 8, 2025, EYPT annual net profit margin is -153.84%, with the most recent change of +93.13% (+37.71%) on December 31, 2023.
- During the last 3 years, EYPT annual net margin has fallen by -22.02% (-16.70%).
- EYPT annual net margin is now -505.16% below its all-time high of 37.97%, reached on June 30, 2010.
Performance
EYPT Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Margin
-278.99%
+46.28%+14.23%
September 30, 2024
Summary
- As of February 8, 2025, EYPT quarterly net profit margin is -278.99%, with the most recent change of +46.28% (+14.23%) on September 30, 2024.
- Over the past year, EYPT quarterly net margin has dropped by -196.03% (-236.29%).
- EYPT quarterly net margin is now -435.53% below its all-time high of 83.15%, reached on June 30, 2010.
Performance
EYPT Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Margin Formula
Net Margin = Net Income
Revenue ✕ 100%
Revenue ✕ 100%
EYPT Net Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +37.7% | -236.3% |
| 3 y3 years | -16.7% | +32.4% |
| 5 y5 years | +89.9% | +32.4% |
EYPT Net Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +37.7% | -236.3% | +32.4% |
| 5 y | 5-year | -16.7% | +44.8% | -1051.9% | +32.4% |
| alltime | all time | -505.2% | +96.7% | -435.5% | +97.9% |
EyePoint Pharmaceuticals Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -278.99%(-14.2%) |
| Jun 2024 | - | -325.27%(+29.8%) |
| Mar 2024 | - | -250.63%(+149.4%) |
| Dec 2023 | -153.84%(-37.7%) | -100.51%(+21.2%) |
| Sep 2023 | - | -82.96%(-67.0%) |
| Jun 2023 | - | -251.73%(-8.6%) |
| Mar 2023 | - | -275.47%(-33.2%) |
| Dec 2022 | -246.97%(+56.2%) | -412.53%(+124.2%) |
| Sep 2022 | - | -183.98%(+9.6%) |
| Jun 2022 | - | -167.80%(-25.7%) |
| Mar 2022 | - | -225.69%(+34.1%) |
| Dec 2021 | -158.14%(+20.0%) | -168.33%(-8.7%) |
| Sep 2021 | - | -184.29%(+65.9%) |
| Jun 2021 | - | -111.06%(-33.8%) |
| Mar 2021 | - | -167.69%(-22.7%) |
| Dec 2020 | -131.82%(-52.7%) | -216.93%(+795.7%) |
| Sep 2020 | - | -24.22%(-92.3%) |
| Jun 2020 | - | -314.17%(+78.6%) |
| Mar 2020 | - | -175.91%(+45.9%) |
| Dec 2019 | -278.88%(-81.7%) | -120.58%(-80.7%) |
| Sep 2019 | - | -623.63%(+291.1%) |
| Jun 2019 | - | -159.47%(-83.3%) |
| Mar 2019 | - | -956.16%(-86.0%) |
| Dec 2018 | -1527.32%(-14.9%) | - |
| Sep 2018 | - | -6816.05%(+41.6%) |
| Jun 2018 | -1795.71%(+632.4%) | -4815.10%(+540.4%) |
| Mar 2018 | - | -751.94%(+21.3%) |
| Dec 2017 | - | -619.72%(-60.1%) |
| Sep 2017 | - | -1554.03%(+78.1%) |
| Jun 2017 | -245.19%(-81.6%) | -872.47%(+0.1%) |
| Mar 2017 | - | -871.19%(>+9900.0%) |
| Dec 2016 | - | -1.12%(-100.0%) |
| Sep 2016 | - | -2585.56%(+23.1%) |
| Jun 2016 | -1330.06%(-5667.4%) | -2100.99%(+35.0%) |
| Mar 2016 | - | -1555.86%(+57.8%) |
| Dec 2015 | - | -985.93%(-6.9%) |
| Sep 2015 | - | -1058.58%(-15.9%) |
| Jun 2015 | 23.89%(-106.2%) | -1258.19%(-17.4%) |
| Mar 2015 | - | -1523.78%(+94.8%) |
| Dec 2014 | - | -782.15%(-1062.4%) |
| Sep 2014 | - | 81.27%(-106.0%) |
| Jun 2014 | -384.54%(-30.8%) | -1358.56%(+1137.4%) |
| Mar 2014 | - | -109.79%(-81.5%) |
| Dec 2013 | - | -593.58%(-3.9%) |
| Sep 2013 | - | -617.59%(-23.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2013 | -555.30%(-21.2%) | -802.24%(+47.3%) |
| Mar 2013 | - | -544.64%(+22.2%) |
| Dec 2012 | - | -445.81%(-3.4%) |
| Sep 2012 | - | -461.30%(+42.5%) |
| Jun 2012 | -704.34%(+305.3%) | -323.61%(-35.2%) |
| Mar 2012 | - | -499.26%(-82.0%) |
| Dec 2011 | - | -2771.43%(+1794.5%) |
| Sep 2011 | - | -146.29%(+3780.4%) |
| Jun 2011 | -173.78%(-557.7%) | -3.77%(-99.5%) |
| Mar 2011 | - | -745.83%(+14.6%) |
| Dec 2010 | - | -650.97%(-0.3%) |
| Sep 2010 | - | -652.94%(-885.3%) |
| Jun 2010 | 37.97%(-283.9%) | 83.15%(-115.8%) |
| Mar 2010 | - | -525.24%(>+9900.0%) |
| Dec 2009 | - | -0.70%(-98.5%) |
| Sep 2009 | - | -47.03%(+183.8%) |
| Jun 2009 | -20.65%(-99.1%) | -16.57%(-17.6%) |
| Mar 2009 | - | -20.11%(-31.3%) |
| Dec 2008 | - | -29.29%(+74.4%) |
| Sep 2008 | - | -16.79%(-99.3%) |
| Jun 2008 | -2176.93%(-53.1%) | -2352.16%(+131.8%) |
| Mar 2008 | - | -1014.94%(-77.6%) |
| Dec 2007 | - | -4527.34%(+486.6%) |
| Sep 2007 | - | -771.84%(-73.9%) |
| Jun 2007 | -4638.70%(+225.0%) | -2953.63%(-77.9%) |
| Mar 2007 | - | -13.39 K%(+541.5%) |
| Dec 2006 | - | -2087.99%(+111.4%) |
| Jun 2006 | -1427.51%(-30.1%) | -987.84%(-38.2%) |
| Mar 2006 | - | -1597.97%(+85.9%) |
| Dec 2005 | - | -859.51%(-46.2%) |
| Sep 2005 | - | -1597.96%(-45.6%) |
| Jun 2005 | -2042.88%(+111.7%) | -2938.01%(+65.4%) |
| Mar 2005 | - | -1776.48%(+0.0%) |
| Dec 2004 | - | -1776.47%(0.0%) |
| Sep 2004 | - | -1776.47%(+84.1%) |
| Jun 2004 | -965.00%(-61.4%) | -965.01%(+0.0%) |
| Mar 2004 | - | -964.99%(-0.0%) |
| Dec 2003 | - | -965.00%(0.0%) |
| Sep 2003 | - | -965.00%(-61.4%) |
| Jun 2003 | -2498.46%(+472.9%) | -2498.54%(+0.0%) |
| Mar 2003 | - | -2498.37%(-0.0%) |
| Dec 2002 | - | -2498.47%(+0.0%) |
| Sep 2002 | - | -2498.46% |
| Jun 2002 | -436.07%(-42.1%) | - |
| Jun 2001 | -752.78% | - |
FAQ
- What is EyePoint Pharmaceuticals annual net profit margin?
- What is the all time high annual net margin for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals annual net margin year-on-year change?
- What is EyePoint Pharmaceuticals quarterly net profit margin?
- What is the all time high quarterly net margin for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals quarterly net margin year-on-year change?
What is EyePoint Pharmaceuticals annual net profit margin?
The current annual net margin of EYPT is -153.84%
What is the all time high annual net margin for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high annual net profit margin is 37.97%
What is EyePoint Pharmaceuticals annual net margin year-on-year change?
Over the past year, EYPT annual net profit margin has changed by +93.13% (+37.71%)
What is EyePoint Pharmaceuticals quarterly net profit margin?
The current quarterly net margin of EYPT is -278.99%
What is the all time high quarterly net margin for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high quarterly net profit margin is 83.15%
What is EyePoint Pharmaceuticals quarterly net margin year-on-year change?
Over the past year, EYPT quarterly net profit margin has changed by -196.03% (-236.29%)